People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Other, Healthtech, Other Technology, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| K2M Group Holdings, Inc. | — | Other | Series D+ | $228.3M | $3.9B | 2010 |
| Vertos Medical Inc | — | Healthtech | Series C | $177.3M | $513.6M | 2011 |
| Valeritas Inc | — | Other Technology | Series C | $106.5M | $689.9M | 2011 |
| Alucent Biomedical, Inc. | — | Biotechnology | Series B | $46.6M | $134.0M | 2023 |
| Mardil, Inc. | — | Other Health Care | Series A | $12.8M | $18.2M | 2010 |
Daniel Pelak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Pelak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 2 | 17 |
| Myles Greenberg | 2 | 6 |
| Ittai Harel | 2 | 6 |
| Sean Traynor | 2 | 3 |
| James Corbett | 2 | 3 |
| Paul Queally | 2 | 2 |
| Andrew Firlik | 1 | 14 |
| Todd Foley | 1 | 12 |
| Bruce Feuchter | 1 | 12 |
| Daniel M. Watkins | 1 | 5 |
| Daniel Watkins | 1 | 4 |
| Michael Elliot | 1 | 4 |
| Nick Pappas | 1 | 4 |
| Michael Bigham | 1 | 3 |
| John Barr | 1 | 3 |
| Myles D. Greenberg | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| Ramesh Alur | 1 | 3 |
| Hugo Harrod | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.